Literature DB >> 31938463

Antimalarial N 1,N 3-Dialkyldioxonaphthoimidazoliums: Synthesis, Biological Activity, and Structure-activity Relationships.

Stephen Ahenkorah1, Dina Coertzen2, Jie Xin Tong1, Kevin Fridianto1, Sergio Wittlin3,4, Lyn-Marie Birkholtz2, Kevin S W Tan1, Yulin Lam1, Mei-Lin Go1, Richard K Haynes5.   

Abstract

Here we report the nanomolar potencies of N 1,N 3-dialkyldioxonaphthoimidazoliums against asexual forms of sensitive and resistant Plasmodium falciparum. Activity was dependent on the presence of the fused quinone-imidazolium entity and lipophilicity imparted by the N1/N3 alkyl residues on the scaffold. Gametocytocidal activity was also detected, with most members active at IC50 < 1 μM. A representative analog with good solubility, limited PAMPA permeability, and microsomal stability demonstrated oral efficacy on a humanized mouse model of P. falciparum.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31938463      PMCID: PMC6956359          DOI: 10.1021/acsmedchemlett.9b00457

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

1.  High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.

Authors:  Jie Xin Tong; Rajesh Chandramohanadas; Kevin Shyong-Wei Tan
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite.

Authors:  I K Srivastava; H Rottenberg; A B Vaidya
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.

Authors:  Tanaji T Talele
Journal:  J Med Chem       Date:  2016-06-30       Impact factor: 7.446

5.  YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer.

Authors:  Kentaro Yamanaka; Mari Nakata; Naoki Kaneko; Hiroshi Fushiki; Aya Kita; Takahito Nakahara; Hiroshi Koutoku; Masao Sasamata
Journal:  Int J Oncol       Date:  2011-06-14       Impact factor: 5.884

6.  The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity.

Authors:  Branka Radic; Cristina Mayor-Ruiz; Georg E Winter; Vincent A Blomen; Claudia Trefzer; Richard K Kandasamy; Kilian V M Huber; Manuela Gridling; Doris Chen; Thorsten Klampfl; Robert Kralovics; Stefan Kubicek; Oscar Fernandez-Capetillo; Thijn R Brummelkamp; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2014-07-27       Impact factor: 16.174

Review 7.  Antimalarial pharmacology and therapeutics of atovaquone.

Authors:  Gemma L Nixon; Darren M Moss; Alison E Shone; David G Lalloo; Nicholas Fisher; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini
Journal:  J Antimicrob Chemother       Date:  2013-01-04       Impact factor: 5.790

8.  Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.

Authors:  Janette Reader; Mariëtte Botha; Anjo Theron; Sonja B Lauterbach; Claire Rossouw; Dewaldt Engelbrecht; Melanie Wepener; Annél Smit; Didier Leroy; Dalu Mancama; Theresa L Coetzer; Lyn-Marie Birkholtz
Journal:  Malar J       Date:  2015-05-22       Impact factor: 2.979

Review 9.  New developments in anti-malarial target candidate and product profiles.

Authors:  Jeremy N Burrows; Stephan Duparc; Winston E Gutteridge; Rob Hooft van Huijsduijnen; Wiweka Kaszubska; Fiona Macintyre; Sébastien Mazzuri; Jörg J Möhrle; Timothy N C Wells
Journal:  Malar J       Date:  2017-01-13       Impact factor: 2.979

10.  Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.

Authors:  William L Hamilton; Roberto Amato; Rob W van der Pluijm; Christopher G Jacob; Huynh Hong Quang; Nguyen Thanh Thuy-Nhien; Tran Tinh Hien; Bouasy Hongvanthong; Keobouphaphone Chindavongsa; Mayfong Mayxay; Rekol Huy; Rithea Leang; Cheah Huch; Lek Dysoley; Chanaki Amaratunga; Seila Suon; Rick M Fairhurst; Rupam Tripura; Thomas J Peto; Yok Sovann; Podjanee Jittamala; Borimas Hanboonkunupakarn; Sasithon Pukrittayakamee; Nguyen Hoang Chau; Mallika Imwong; Mehul Dhorda; Ranitha Vongpromek; Xin Hui S Chan; Richard J Maude; Richard D Pearson; T Nguyen; Kirk Rockett; Eleanor Drury; Sónia Gonçalves; Nicholas J White; Nicholas P Day; Dominic P Kwiatkowski; Arjen M Dondorp; Olivo Miotto
Journal:  Lancet Infect Dis       Date:  2019-07-22       Impact factor: 71.421

View more
  2 in total

1.  Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosis.

Authors:  Kevin T Fridianto; Ming Li; Kiel Hards; Dereje A Negatu; Gregory M Cook; Thomas Dick; Yulin Lam; Mei-Lin Go
Journal:  J Med Chem       Date:  2021-10-27       Impact factor: 7.446

2.  Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue.

Authors:  Jerome P L Ng; Yu Han; Li Jun Yang; Lyn-Marie Birkholtz; Dina Coertzen; Ho Ning Wong; Richard K Haynes; Paolo Coghi; Vincent Kam Wai Wong
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.